Moreover, the results of the tumor-infiltrating cells analysis showed that NR2F6 expression significantly correlates with infiltrating stromal and immune cells in the glioma microenvironment. More interestingly, we found that NR2F6 was expressed in both immune and malignant cells, as well as stromal cells in glioma patients using the TISCH database. The gene discussed is NR2F6; the disease is neoplasm.